Please enable JavaScript.
Coggle requires JavaScript to display documents.
acute myeloid leukemia (AML) (AML with recurrent genetic abnormalities…
acute myeloid leukemia (AML)
AML with recurrent genetic abnormalities
AML with t(8;21)(q22;q22); RUNX1-RUNX1T1b
AML with inv(16)(pl3.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11b
Acute promyelocytic leukemia with t(15;17)(q22;q12); PML-RARAb
AML with t(9;11)(p22;q23); MLLT3-MLL
AML with t(6;9)(p23;q34); DEK-NUP214
AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
AML (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
Provisional entity: AML with mutated NPM1
Provisional entity: AML with mutated CEBPA
AML with myelodysplasia-related changes
therapy-related myeloid neoplasms
AML not otherwise specified
AML with minimal differential
AML without maturation
AML with maturation
acute myelemonocytic leukemia
acute monoblastic and monocytic leukemia
acute erythroid leukemia
acute megakaryoblastic leukemia
acute basophilic leukemia
acute panmyelosis with myelofibrosis
myeloid sarcoma
myeloid proliferations related to Down syndrome
transient abnormal myelopoiesis
myeloid leukemia associated with Down syndrome
blastic plasmacytoid dendritic cell neoplasm